Please assess the completion status of the following clinical trial:

Trial Title: Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically or cytologically confirmed diagnosis of locally advanced high-risk eligible tumor types .~* Participant must be greater than or equal to (\>=)18 years of age (or \>=10 years of age with synovial sarcoma or myxoid/round cell liposarcoma \[MRCLS\])~* Participants with life expectancy of greater than 6 months~* Performance status: Eastern Cooperative Oncology Group 0-1.~Exclusion Criteria:~* Any prior treatment with oncology cell and/or gene therapy (unless agreed in advance with Sponsor)~* Prior malignancy not in complete remission.~* Clinically significant systemic illness~* Serious active infections or significant cardiac, pulmonary, hepatic or other organ dysfunction,~* Prior or active demyelinating disease~* Previous New-York Esophageal Antigen-1 (NY-ESO-1)-specific T cells, NY-ESO-1 vaccine, or NY-ESO-1 targeting antibody.~* Previous allogeneic hematopoietic stem cell transplant within the last 5 years or solid organ transplant.

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Participants with solid tumors and hematological malignancies (Type: OTHER): Participants with solid tumors and hematological malignancies will be included. No study treatment will be administered in this study.

Based on this trial design, predict the completion outcome and termination type (if applicable).